No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs2838225 |
chr21:44690691-44690692 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs117049096 |
chr21:44690739-44690740 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs543164789 |
chr21:44690741-44690742 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs530763120 |
chr21:44690747-44690748 |
Weak transcription Enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs150840357 |
chr21:44690856-44690857 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs112789589 |
chr21:44690912-44690913 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs375867922 |
chr21:44690926-44690927 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs199999318 |
chr21:44691061-44691062 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
9 |
rs11700472 |
chr21:44691106-44691107 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
10 |
rs555298211 |
chr21:44691193-44691194 |
Weak transcription Enhancers Genic enhancers Bivalent Enhancer Flanking Active TSS
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
11 |
rs200943119 |
chr21:44691243-44691244 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
12 |
rs138496442 |
chr21:44691270-44691271 |
Weak transcription Genic enhancers Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
13 |
rs371638148 |
chr21:44691406-44691407 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
14 |
rs544725549 |
chr21:44691456-44691457 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
15 |
rs117497971 |
chr21:44691463-44691464 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
16 |
rs568664108 |
chr21:44691477-44691478 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
17 |
rs563553113 |
chr21:44691615-44691616 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
18 |
rs113488507 |
chr21:44691733-44691734 |
Weak transcription Enhancers Bivalent Enhancer
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
19 |
rs118153903 |
chr21:44691806-44691807 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
20 |
rs374193390 |
chr21:44691841-44691842 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
21 |
rs202187195 |
chr21:44691854-44691855 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
22 |
rs567325600 |
chr21:44691855-44691856 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
23 |
rs376215308 |
chr21:44691894-44691895 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
24 |
rs371651520 |
chr21:44692117-44692118 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
25 |
rs377025948 |
chr21:44692190-44692191 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
26 |
rs576496409 |
chr21:44692250-44692251 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
27 |
rs373672693 |
chr21:44692254-44692255 |
Weak transcription Enhancers
|
Chromatin interactive region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
28 |
rs571814349 |
chr21:44692306-44692307 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs117184908 |
chr21:44692326-44692327 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs538984563 |
chr21:44692351-44692352 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs144025638 |
chr21:44692364-44692365 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs569497418 |
chr21:44692389-44692390 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs536568179 |
chr21:44692392-44692393 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs118031621 |
chr21:44692443-44692444 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs371240156 |
chr21:44692493-44692494 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs372918044 |
chr21:44692558-44692559 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs555274824 |
chr21:44692598-44692599 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs573088978 |
chr21:44692600-44692601 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs537616524 |
chr21:44692672-44692673 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs111547698 |
chr21:44692698-44692699 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs17004515 |
chr21:44692863-44692864 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs369763005 |
chr21:44692873-44692874 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs374209241 |
chr21:44692961-44692962 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs113881620 |
chr21:44692970-44692971 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs540466652 |
chr21:44692997-44692998 |
Weak transcription Enhancers Bivalent Enhancer
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
46 |
rs9976875 |
chr21:44693038-44693039 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs386819031 |
chr21:44693064-44693065 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs201704499 |
chr21:44693066-44693067 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs552648756 |
chr21:44693070-44693071 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs377078750 |
chr21:44693072-44693073 |
Weak transcription Bivalent Enhancer Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|